圣诺生物：2025年净利润1.66亿元，同比增长231.49%

Core Viewpoint - Shengnuo Bio reported significant growth in its financial performance for the fiscal year 2025, indicating strong operational momentum and profitability improvements [1] Financial Performance - The company achieved operating revenue of 741 million yuan, representing a year-on-year increase of 62.55% [1] - The net profit attributable to the owners of the parent company reached 166 million yuan, reflecting a substantial year-on-year growth of 231.49% [1] - The net profit attributable to the owners of the parent company, after deducting non-recurring gains and losses, was 173 million yuan, marking an impressive year-on-year increase of 278.52% [1]